Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better.

From the week of December 1st, we are planning to work on 23 projects, including:

Reimbursement

1. Working on market access strategy for the administration of a medication in outpatient settings in England, France, Germany, and Sweden
2. Working on marker access strategy for a minimally invasive orthopedic procedure in France
3. Working on reimbursement analysis for home-based in-vitro diagnostic tests in nine European countries 
4. Working on reimbursement analysis for cancer treatment in Turkey 
5. Working on reimbursement analysis for gastrointestinal minimally invasive surgery in England, France, Germany, and Italy
6. Working on reimbursement analysis for liver and kidney surgery in England, France, Germany, and Italy
7. Working on market access strategy for minimally invasive technology in the urology area in eight European countries
8. Working on reimbursement analysis for cardiovascular and peripheral vascular procedures in Austria, Italy, and Spain
9. Working on reimbursement analysis for endoscopic gastrointestinal procedures in Denmark, Finland, Norway, and Sweden
10. Working on reimbursement analysis for cardiac surgery procedures in Belgium, Denmark, the Netherlands, and Sweden 
11. Working on the procedure code application for diagnostic technology in the gastrointestinal area in Sweden
12. Working on reimbursement analysis for blood test in England, France, Germany, Italy and Spain
13. Initiating work on reimbursement analysis for invasive diagnostic imaging technology in the cardiovascular area in England, France, and Germany

HEOR

1. Delivering a systematic review and meta-analysis for an in vitro diagnostic test
2. Delivering a clinical value dossier for an in vitro diagnostic test in the neurology area 
3. Delivering a literature review of patient pathways in the oncology area in France
4. Delivering the adaptation of a health economic model for treatment methods in the dermatology area in Italy
5. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain 
6. Working on evidence gap analysis for a minimally invasive orthopedic procedure in France 
7. Working on a clinical value dossier for treatment technology in the dermatology area
8. Working on the literature review of treatment in the urology area in European countries 
9. Working on the adaptation of a health economic model for an imaging diagnostic system in different European and Middle Eastern countries
10. Working on a systematic literature review update for a minimally invasive technology in the neurology area
11. Working on the validation of a health economic model in the cardiology area
12. Initiating work on a health economic analysis for a treatment method in the cardiology area

Let us know if you need any market access or HEOR support for your medical technology in Europe.